Genetic engineering of glomerular sclerosis in the mouse via control of onset and severity of podocyte-specific injury.

This study aimed to generate a mouse model of acquired glomerular sclerosis. A model system that allows induction of podocyte injury in a manner in which onset and severity can be controlled was designed. A transgenic mouse strain (NEP25) that expresses human CD25 selectively in podocytes was first generated. Injection of anti-Tac (Fv)-PE38 (LMB2), an immunotoxin with specific binding to human CD25, induced progressive nonselective proteinuria, ascites, and edema in NEP25 mice. Podocytes showed foot process effacement, vacuolar degeneration, detachment and downregulation of synaptopodin, WT-1, nephrin, and podocalyxin. Mesangial cells showed matrix expansion, increased collagen, mesangiolysis, and, later, sclerosis. Parietal epithelial cells showed vacuolar degeneration and proliferation, whereas endothelial cells were swollen. The severity of the glomerular injury was LMB2 dose dependent. With 1.25 ng/g body wt or more, NEP25 mice developed progressive glomerular damage and died within 2 wk. With 0.625 ng/g body wt of LMB2, NEP25 mice survived >4 wk and developed focal segmental glomerular sclerosis. Thus, the study has established a mouse model of acquired progressive glomerular sclerosis in which onset and severity can be preprogrammed by experimental maneuvers.

[1]  B. Smeets,et al.  The parietal epithelial cell: a key player in the pathogenesis of focal segmental glomerulosclerosis in Thy-1.1 transgenic mice. , 2004, Journal of the American Society of Nephrology : JASN.

[2]  M. Kretzler,et al.  Early Glomerular Filtration Defect and Severe Renal Disease in Podocin-Deficient Mice , 2004, Molecular and Cellular Biology.

[3]  I. Pastan,et al.  Conditional Ablation of Striatal Neuronal Types Containing Dopamine D2 Receptor Disturbs Coordination of Basal Ganglia Function , 2003, The Journal of Neuroscience.

[4]  R. Gerszten,et al.  Mice deficient in α-actinin-4 have severe glomerular disease , 2003 .

[5]  E. Unanue,et al.  CD2-Associated Protein Haploinsufficiency Is Linked to Glomerular Disease Susceptibility , 2003, Science.

[6]  J. Haigh,et al.  Glomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases. , 2003, The Journal of clinical investigation.

[7]  S. Shankland,et al.  Podocyte biology and response to injury. , 2002, Journal of the American Society of Nephrology : JASN.

[8]  P. Klotman,et al.  Recent progress in HIV-associated nephropathy. , 2002, Journal of the American Society of Nephrology : JASN.

[9]  M. Pollak.  Inherited podocytopathies: FSGS and nephrotic syndrome from a genetic viewpoint. , 2002, Journal of the American Society of Nephrology : JASN.

[10]  L. Holzman,et al.  Two gene fragments that direct podocyte-specific expression in transgenic mice. , 2002, Journal of the American Society of Nephrology : JASN.

[11]  D. Kerjaschki.  Caught flat-footed: podocyte damage and the molecular bases of focal glomerulosclerosis. , 2001, The Journal of clinical investigation.

[12]  Y. H. Kim,et al.  Podocyte depletion and glomerulosclerosis have a direct relationship in the PAN-treated rat. , 2001, Kidney international.

[13]  I. Pastan,et al.  Inhibition of TNF-α Produced by Kupffer Cells Protects Against the Nonspecific Liver Toxicity of Immunotoxin Anti-Tac(Fv)-PE38, LMB-2 , 2000, The Journal of Immunology.

[14]  L. Holzman,et al.  Evaluation of a new tool for exploring podocyte biology: mouse Nphs1 5' flanking region drives LacZ expression in podocytes. , 2000, Journal of the American Society of Nephrology : JASN.

[15]  I. Pastan,et al.  Site-specific chemical modification with polyethylene glycol of recombinant immunotoxin anti-Tac(Fv)-PE38 (LMB-2) improves antitumor activity and reduces animal toxicity and immunogenicity. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[16]  Corinne Antignac,et al.  NPHS2, encoding the glomerular protein podocin, is mutated in autosomal recessive steroid-resistant nephrotic syndrome , 2000, Nature Genetics.

[17]  J. D. White,et al.  Phase I trial of recombinant immunotoxin anti-Tac(Fv)-PE38 (LMB-2) in patients with hematologic malignancies. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[18]  J. Kaplan,et al.  Mutations in ACTN4, encoding α-actinin-4, cause familial focal segmental glomerulosclerosis , 2000, Nature Genetics.

[19]  I. Pastan,et al.  Reduction of the nonspecific animal toxicity of anti-Tac(Fv)-PE38 by mutations in the framework regions of the Fv which lower the isoelectric point. , 1999, Journal of immunology.

[20]  Michael Loran Dustin,et al.  Congenital nephrotic syndrome in mice lacking CD2-associated protein. , 1999, Science.

[21]  K. Toyama,et al.  Ablation of Cerebellar Golgi Cells Disrupts Synaptic Integration Involving GABA Inhibition and NMDA Receptor Activation in Motor Coordination , 1998, Cell.

[22]  N. Gretz,et al.  Progression of glomerular diseases: is the podocyte the culprit? , 1998, Kidney international.

[23]  I. Pastan,et al.  Accumulation of a recombinant immunotoxin in a tumor in vivo: fewer than 1000 molecules per cell are sufficient for complete responses. , 1998, Cancer research.

[24]  L Peltonen,et al.  Positionally cloned gene for a novel glomerular protein--nephrin--is mutated in congenital nephrotic syndrome. , 1998, Molecular cell.

[25]  I. Pastan,et al.  Autonomic neuropathy in transgenic mice caused by immunotoxin targeting of the peripheral nervous system , 1998, Journal of neuroscience research.

[26]  I. Pastan,et al.  Immunotoxin-mediated conditional disruption of specific neurons in transgenic mice. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[27]  H. Rennke.  How does glomerular epithelial cell injury contribute to progressive glomerular damage? , 1994, Kidney international. Supplement.

[28]  M. Karnovsky,et al.  Focal and segmental glomerulosclerosis following a single intravenous dose of puromycin aminonucleoside. , 1986, The American journal of pathology.

[29]  Michael Af,et al.  Experimental model of focal sclerosis. I. Relationship to protein excretion in aminonucleoside nephrosis. , 1977 .

[30]  Michael Af,et al.  Experimental model of focal sclerosis. II. Correlation with immunopathologic changes, macromolecular kinetics, and polyanion loss. , 1977 .

[31]  Andrews Pm.  A scanning and transmission electron microscopic comparison of puromycin aminonucleoside-induced nephrosis to hyperalbuminemia-induced proteinuria with emphasis on kidney podocyte pedicel loss. , 1977, Laboratory investigation; a journal of technical methods and pathology.

[32]  A. Michael,et al.  The glomerular mesangium. I. Kinetic studies of macromolecular uptake in normal and nephrotic rats. , 1972, The Journal of clinical investigation.

[33]  Matthias Kretzler,et al.  Cell biology of the glomerular podocyte. , 2003, Physiological reviews.

[34]  R. Gerszten,et al.  Mice deficient in alpha-actinin-4 have severe glomerular disease. , 2003, The Journal of clinical investigation.

[35]  K. Tryggvason,et al.  The murine nephrin gene is specifically expressed in kidney, brain and pancreas: inactivation of the gene leads to massive proteinuria and neonatal death. , 2001, Human molecular genetics.

[36]  J. Kaplan,et al.  Mutations in ACTN4, encoding alpha-actinin-4, cause familial focal segmental glomerulosclerosis. , 2000, Nature genetics.

[37]  H. Endou,et al.  An adenosine deaminase inhibitor prevents puromycin aminonucleoside nephrotoxicity. , 1997, Free radical biology & medicine.

[38]  P. Steels,et al.  A new single nephron model of focal and segmental glomerulosclerosis in the Munich-Wistar rat. , 1994, Kidney international.

[39]  F. Coe,et al.  Increased urinary saturation and kidney calcium content in genetic hypercalciuric rats. , 1994, Kidney international.

[40]  I. Pastan,et al.  Recombinant immunotoxins containing anti-Tac(Fv) and derivatives of Pseudomonas exotoxin produce complete regression in mice of an interleukin-2 receptor-expressing human carcinoma. , 1994, Blood.

[41]  A. Michael,et al.  Experimental model of focal sclerosis. I. Relationship to protein excretion in aminonucleoside nephrosis. , 1977, Laboratory investigation; a journal of technical methods and pathology.

[42]  A. Michael,et al.  Experimental model of focal sclerosis. II. Correlation with immunopathologic changes, macromolecular kinetics, and polyanion loss. , 1977, Laboratory investigation; a journal of technical methods and pathology.

[43]  P. Andrews.  A scanning and transmission electron microscopic comparison of puromycin aminonucleoside-induced nephrosis to hyperalbuminemia-induced proteinuria with emphasis on kidney podocyte pedicel loss. , 1977, Laboratory investigation; a journal of technical methods and pathology.